Prostate Cancer
Cancer Research Foundation Awards Prestigious Clinical Investigator Award to Two Weill Cornell Medicine Scientists
Two Weill Cornell Medicine scientists have received the Damon Runyon Cancer Research Clinical Investigator Award for 2016 for their innovative research: Dr. Christopher Barbieri and Dr. Heather Yeo.
Read the full article here.
Dr. Barbieri on SPOP Mutations in Prostate Cancer (OncLive)
Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer genomics, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New-York Presbyterian, discusses the implications of SPOP mutations in patients with prostate cancer.
Weill Cornell Medicine Urology – Lower Manhattan
Appointments: (646) 962-9600
For word-class and compassionate urologic care in downtown Manhattan, Weill Cornell Medicine and Brady Urologic Associates has a clinical urology practice at 156 William Street and affiliated with New York-Presbyterian Lower Manhattan Hospital. This practice is housed in a newly renovated clinical space, equipped with state-of-the-art medical technologies, exam rooms, and procedure rooms.
NewYork-Presbyterian Hospital - LeFrak Center for Robotic Surgery
Appointments: (646) 962-9600
The LeFrak Center for Robotic Surgery is home to a partnership between the most technologically-advanced surgical robots and the most experienced and dedicated surgical team. The Center is led by the internationally renowned surgeon, Dr. Jim C. Hu.
Our patient approach is on a dedicated and individual basis. Our clinical staff will provide a clear and compassionate guide for all possible treatment paths.
Reevaluating PSA Testing Rates in the PLCO Trial
Dr. Jim C. Hu and Dr. Jonathan Shoag detail the controversy surrounding PSA testing. Read more at the New England Journal of Medicine here.
Scott T. Tagawa
Scott T. Tagawa, MD was initially appointed to the faculty of Weill Cornell Medical College in April, 2007 as Assistant Professor of Medicine and Urology and Assistant Attending Physician in the Division of Hematology and Medical Oncology. He joined the Genitourinary Oncology Program within the Solid Tumor Service in the Division of Hematology and Medical Oncology.
Christopher E. Barbieri
Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.
Douglas Scherr
Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy, as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology, I continually interact with colleagues in the areas of medical oncology, radiation oncology, and pathology, among others, in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer.
David M. Nanus
Dr. David Nanus joined New York Presbyterian Hospital in 1998 as medical director of the Genitourinary Oncology Program with a joint appointment as associate professor of medicine and urology. Dr. Nanus came to New York Hospital from Memorial Sloan-Kettering Cancer Center where he was an assistant attending physician in the Genitourinary Oncology Service within the Division of Solid Tumor Oncology and Director of the Genitourinary Oncology Research Laboratory.
Jim C. Hu
Dr. Jim Hu is a urologic oncologist with his undergraduate degree in Economics, his Master’s in Public Health in Health Policy and Management from Johns Hopkins University, and his Medical Degree from Baylor College of Medicine. He completed his Urology Residency at the David Geffen School of Medicine at UCLA and his Robotic Surgery/Urologic Oncology Fellowship in 2004 at City of Hope National Medical Center.
